Patents by Inventor Tanja Ouimet

Tanja Ouimet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMINO ACID DERIVATIVES CONTAINING A DISULFANYL GROUP AS AN INHIBITOR OF NEP AND APN FOR THE PREVENTION AND TREATMENT OF TRIGEMINAL NERVE PAIN
    Publication number: 20230241021
    Abstract: The present invention concerns a pharmaceutically acceptable salt of a compound of the following formula (I): H2N—CH(R1)—CH2S—S—CH2—CH(R2—CONH—CH(R3)—COOR4 (I) and more particularly an acid addition salt thereof, and the compositions comprising the same, for use in the prevention or treatment of trigeminal nerve pain, in particular migraines or trigeminal neuralgia.
    Type: Application
    Filed: April 7, 2023
    Publication date: August 3, 2023
    Inventors: Hervé Poras, Tanja Ouimet, Marie Claude Fournie Zaluski, Bernard Roques, Michel Wurm
  • Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain
    Patent number: 11648231
    Abstract: The present invention concerns a pharmaceutically acceptable salt of a compound of the following formula (I): H2N—CH(R1)—CH2S—S—CH2—CH(R2—CONH—CH(R3)—COOR4 (I) and more particularly an acid addition salt thereof, and the compositions comprising the same, for use in the prevention or treatment of trigeminal nerve pain, in particular migraines or trigeminal neuralgia.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: May 16, 2023
    Assignee: PHARMALEADS
    Inventors: Hervé Poras, Tanja Ouimet, Marie Claude Fournie Zaluski, Bernard Roques, Michel Wurm
  • AMINO ACID DERIVATIVES CONTAINING A DISULFANYL GROUP IN THE FORM OF AN NEP AND APN INHIBITOR FOR THE PREVENTION AND TREATMENT OF TRIGEMINAL NERVE PAIN
    Publication number: 20210052539
    Abstract: The present invention concerns a pharmaceutically acceptable salt of a compound of the following formula (I): H2N—CH(R1)—CH2S—S—CH2—CH(R2—CONH—CH(R3)—COOR4 (I) and more particularly an acid addition salt thereof, and the compositions comprising the same, for use in the prevention or treatment of trigeminal nerve pain, in particular migraines or trigeminal neuralgia.
    Type: Application
    Filed: January 25, 2019
    Publication date: February 25, 2021
    Inventors: Hervé Poras, Tanja Ouimet, Marie Claude Fournie Zaluski, Bernard Roques, Michel Wurm
  • SUBSTRATES THE FLUORESCENCE OF WHICH IS SUPPRESSED, PREPARATION THEREOF, AND USE THEREOF FOR IDENTIFYING, DETECTING, AND ASSAYING LEGIONELLA PNEUMOPHILIA
    Publication number: 20130203097
    Abstract: The present disclosure includes the use of an R—(X)n-Fluo-Rep-(Gly)m-Z—NH2 peptide for detecting and assaying the activity of the major surface protease of Legionella pneumophilia. This disclosure also includes a method for detecting and quantifying Legionella pneumophilia in any medium likely to be contaminated with the bacterium, for example a domestic hot water supply and cooling tower circuits.
    Type: Application
    Filed: July 21, 2011
    Publication date: August 8, 2013
    Applicant: PHARMALEADS
    Inventors: Herve Poras, Tanja Ouimet, Marie-Claude Fournie-Zaluski